Market Research Logo

Global Treatment for Neglected Tropical Disease Market 2017-2027

Global Treatment for Neglected Tropical Disease Market 2017-2027

The Global Treatment for Neglected Tropical Disease market is expected to grow at a CAGR of 7.3% in the second half of the forecast period. The Global Treatment for Neglected Tropical Disease market reached $1.5bn in 2016, dominated by the treatments for malaria which held 30% share of the market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 157-page report you will receive 71 tables and 80 figures– all unavailable elsewhere.

The 157-page report provides clear detailed insight into the Global Treatment for Neglected Tropical Disease market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

  • Global Treatment for Neglected Tropical Disease market forecasts from 2017-2027
  • This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by disease type:
  • Malaria treatments
  • Dengue treatments
  • Leishmaniasis
  • Schistosomiasis
  • Lymphatic Filariasis
  • Chagas Disease
  • Others
For each disease type, the report provides a SWOT analysis, a list of selected drugs and revenue forecasts from 2017-2027 of the leading drugs.
  • This report provides revenue forecast for these leading drugs:
  • Coartem (Novartis)
  • Clindamycin (Pfizer)
  • Dengvaxia (Sanofi)
  • AmBisome (Gilead Sciences)
  • Impavido (Knight Therapeutics)
  • ALBENZA (Amedra Pharmaceuticals LLC)
  • This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by regional and national market:
  • North America: US and Canada
  • Europe: Germany, the UK, France, Spain, Italy, Rest of Europe
  • Asia-Pacific: Japan, China, India, Rest of Asia
  • Latin America: Brazil, Mexico, Rest of Latin America
  • Middle East & Africa: Saudi Arabia, South of Africa, Rest of Middle East & Africa
Each regional market is further broken down by disease type.
  • This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the neglected tropical disease market:
  • Pfizer, Inc.
  • Bayer
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis International AG
  • Takeda Pharmaceutical Company Ltd
  • Sanofi S.A.
  • Eisai Co., Ltd


Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


1. Report Overview
1.1 Global Treatment for Neglected Tropical Disease Market Overview
1.2 Overview of Findings
1.3 Structure of the Report
1.4 Global Treatment for Neglected Tropical Disease Market Segmentation
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Treatment for Neglected Tropical Disease
2.1 An Introduction to Treatment for Neglected Tropical Disease
2.2. Malaria Treatments
2.3. Dengue Treatments
2.4. Leishmaniasis
2.5 Schistosomiasis
2.6 Lymphatic Filariasis
2.7 Chagas Disease
2.8. Drivers
2.8.1. Increasing prevalence of various neglected tropical disease
2.8.2. Product Launch and Government Initiatives
2.9. Restrains
2.9.1 High Possibilities of Side Effect of Vaccine
3. Global Treatment for Neglected Tropical Disease Market 2017-2027
3.1 Global Treatment for Neglected Tropical Disease Market Forecast 2017-2027
3.2 Changing Market Shares by Segment2017-2027
3.3 Global Malaria Treatments Segment Market: Sales Forecast 2017-2027
3.3.1. Leading Drugs in the Malaria Treatments Market
3.3.1.1. Coartem (Novartis)
3.3.1.2. Clindamycin (Pfizer, Inc.)
3.3.1.3. Other Malaria Drugs
3.3.2. SWOT Analysis of the Malaria Treatments Market, 2017-2027
3.3.2.1. Strength
3.3.2.1.1. Supportive Government policy for Primary Health Care strategies
3.3.2.2. Weakness
3.3.2.2.1. Inadequacies in public health infrastructure, including training facilities
3.3.2.3. Opportunity
3.3.2.3.1. Increasing prevalence of Malaria
3.3.2.4. Threat
3.3.2.4.1. Community resistance to surveillance activities
3.4 Global Dengue treatments Segment Market: Sales Forecast 2017-2027
3.4.1. Dengvaxia (Sanofi)
3.4.2. SWOT Analysis of the Dengue Treatments Market, 2017-2027
3.4.2.1. Strength
3.4.2.1.1. Approval of Dengvaxia
3.4.2.2. Weakness
3.3.2.2.1. Vaccine is not available worldwide
3.4.2.3. Opportunity
3.4.2.3.1. Increasing prevalence of Dengue
3.4.2.4. Threat
3.4.2.4.1. Side Effects of Dengvaxia
3.5 Global Leishmaniasis Segment Market: Sales Forecast 2017-2027
3.5.1. AmBisome (Gilead Sciences)
3.5.2. Impavido (Marketed by Knight Therapeutics)
3.5.3. Leishmaniasis Drugs
3.5.4. SWOT Analysis of the Leishmaniasis Market, 2017-2027
3.5.4.1. Strength
3.5.4.1.1. Availability of vaccines
3.5.4.2. Weakness
3.5.4.2.1. No or less prevalence in developed regions
3.5.4.3. Opportunity
3.5.4.3.1. Increasing Prevalence of Visceral leishmaniasis
3.5.4.4. Threat
3.5.4.4.1. Patient don’t know if they are infected
3.6 Global Schistosomiasis Segment Market: Sales Forecast 2017-2027
3.6.1. SWOT Analysis of the Schistosomiasis Market, 2017-2027
3.6.1.1. Strength
3.6.1.1.1. Increasing prevalence of Schistosomiasis
3.6.1.2. Weakness
3.6.1.2.1. No or less prevalence in North America and Europe
3.6.1.3. Opportunity
3.6.1.3.1. Major patient base in Middle East & Africa
3.6.1.4. Threat
3.6.1.4.1. New Entrants
3.7 Global Lymphatic Filariasis Segment Market: Sales Forecast 2017-2027
3.7.1. ALBENZA (Amedra Pharmaceuticals LLC)
3.7.2. Lymphatic Filariasis Drugs
3.7.3. SWOT Analysis of the Lymphatic Filariasis Market, 2017-2027
3.7.3.1. Strength
3.7.3.1.1. Increasing number of patient treated with lymphatic filariasis
3.7.3.2. Weakness
3.7.3.2.1. Availability of vaccine for the patients
3.7.3.3. Opportunity
3.7.3.3.1. Increasing prevalence of Lymphatic Filariasis
3.7.3.4. Threat
3.7.3.4.1. Side Effects of ALBENZA
3.8 Global Chagas Disease Segment Market: Sales Forecast 2017-2027
3.8.1. Chagas Disease Drugs
3.8.2. SWOT Analysis of the Chagas Disease Market, 2017-2027
3.8.2.1. Strength
3.8.2.1.1. Increasing prevalence rate of underdiagnosed migrants
3.8.2.2. Weakness
3.8.2.2.1. Low prevalence of Chagas Disease in Asia-Pacific and Middle East & Africa
3.8.2.3. Opportunity
3.8.2.3.1. Increasing prevalence of Chagas Disease
3.8.2.4. Threat
3.8.2.4.1. Neglected by market players
3.9 Global Others Segment Market: Sales Forecast 2017-2027
4.Leading National Markets 2017-2027
4.1 Geographical Breakdown of the World Treatment for Neglected Tropical Disease Market
4.2 World Treatment for Neglected Tropical Disease Market: Regional Forecast 2017-2027
4.2.1 How Will Regional Market Shares Change to 2027?
5. North America Treatment for Neglected Tropical Disease Market 2017-2027
5.1. U.S. Treatment for Neglected Tropical Disease Market: Trends and Developments
5.2. Canada Treatment for Neglected Tropical Disease Market: Trends and Developments
6. Europe Treatment for Neglected Tropical Disease Market 2017-2027
6.1. Germany Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.2. France Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.3. U.K. Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.4. Italy Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.5. Spain Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.6. Rest of Europe Treatment for Neglected Tropical Disease Market Forecast 2017-2027
7. Asia-Pacific Treatment for Neglected Tropical Disease Market 2017-2027
7.1. China Treatment for Neglected Tropical Disease Market: Trends and Developments
7.2. Japan Treatment for Neglected Tropical Disease Market: Trends and Developments
7.3. India Treatment for Neglected Tropical Disease Market: Trends and Developments
7.4. Rest of Asia-Pacific Treatment for Neglected Tropical Disease Market: Trends and Developments
8. Latin America Treatment for Neglected Tropical Disease Market 2017-2027
8.1 Brazil Treatment for Neglected Tropical Disease Market: Trends and Developments
8.2. Mexico Treatment for Neglected Tropical Disease Market: Trends and Developments
8.3. Rest of Latin America Treatment for Neglected Tropical Disease Market: Trends and Developments
9. Middle East and Africa Treatment for Neglected Tropical Disease Market 2017-2027
9.1. Saudi Arabia Treatment for Neglected Tropical Disease Market Forecast 2017-2027
9.2. South Africa Treatment for Neglected Tropical Disease Market Forecast 2017-2027
9.3. Rest of Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast 2017-2027
10. Leading Companies in the Treatment for Neglected Tropical Disease Market
10.1. Pfizer, Inc.
10.1.1 Pfizer, Inc.: Treatment for Neglected Tropical Disease Product Portfolio
10.1.2 Pfizer, Inc.: Financial Overview
10.1.3 Pfizer, Inc.: Recent Developments
10.2. Bayer AG
10.2.1 Bayer AG: Treatment for Neglected Tropical Disease Portfolio
10.2.2 Bayer AG: Financial Overview
10.2.3 Bayer AG: Recent Transactions Summary
10.3. GlaxoSmithKline plc
10.3.1 GlaxoSmithKline plc: Treatment for Neglected Tropical Disease Portfolio
10.3.2 GlaxoSmithKline plc: Financial Overview
10.3.3 GlaxoSmithKline plc: Recent Transactions Summary
10.4. Merck & Co., Inc.
10.4.1 Merck & Co., Inc.: Treatment for Neglected Tropical Disease Portfolio
10.4.2 Merck & Co., Inc.: Financial Overview
10.4.3 Merck & Co., Inc.: Recent Transactions Summary
10.5. Novartis AG
10.5.1 Novartis: Treatment for Neglected Tropical Disease Product Portfolio
10.5.2 Novartis: Financial Overview
10.5.3 Novartis: Recent Developments
10.6. Takeda Pharmaceutical Company Ltd
10.6.1 Takeda Pharmaceutical Company Ltd: Treatment for Neglected Tropical Disease Product Portfolio
10.6.2 Takeda Pharmaceutical Company Ltd: Financial Overview
10.6.3 Takeda Pharmaceutical Company Ltd: Recent Developments
10.7. Sanofi S.A.
10.7.1 Sanofi S.A.: Treatment for Neglected Tropical Disease Product Portfolio
10.7.2 Sanofi S.A.: Financial Overview
10.7.3 Sanofi S.A.: Recent Developments
10.8. Eisai Co., Ltd
10.8.1 Eisai Co., Ltd: Treatment for Neglected Tropical Disease Product Portfolio
10.8.2 Eisai Co., Ltd: Financial Overview
10.8.3 Eisai Co., Ltd: Recent Developments
11. Conclusions
11.1 The World Treatment for Neglected Tropical Disease Market in 2016 and 2016
11.1.1 Current Leading Treatment for Neglected Tropical Disease Segments
11.1.2 Leading Regional Markets
11.2 World Treatment for Neglected Tropical Disease Market Forecast 2017-2027
11.3 The Future of the Treatment for Neglected Tropical Disease Market?
Appendices
Associated Visiongain Report
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
List of Tables
Table 3.1 Global Treatment for Neglected Tropical Disease Market by Diseases Types: Revenue ($m) and Market Share (%), 2016
Table 3.2 Global Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.3 Global Malaria Treatments Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.4 Global Coartem Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.5 Global Clindamycin Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.6 Other Malaria Drugs
Table 3.7 SWOT Analysis of the Malria Market, 2017-2027
Table 3.8 Global Dengue Treatments Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.9 Global Dengvaxia Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.10 SWOT Analysis of the Dengue Treatment Market, 2017-2027
Table 3.11 Global Leishmaniasis Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.12 Global AmBisome Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.13 Global Impavido Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.14 Other Leishmaniasis Drugs
Table 3.15 SWOT Analysis of the Leishmaniasis Market, 2017-2027
Table 3.16 Global Schistosomiasis Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.17 SWOT Analysis of the Schistosomiasis Market, 2017-2027
Table 3.18 Global Lymphatic Filariasis Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.19 Global ALBENZA Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.20 Other Lymphatic Filariasis Drugs
Table 3.21 SWOT Analysis of the Lymphatic Filariasis Market, 2017-2027
Table 3.22 Global Chagas Disease Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.23 Other Chagas Disease Drugs
Table 3.24 SWOT Analysis of the Chagas Disease Market, 2017-2027
Table 3.25 Global Others Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 4.1 Global Treatment for Neglected Tropical Disease Market by Region: Revenue ($m), 2016 and 2017
Table 4.2 Global Treatment for Neglected Tropical Disease Market Forecast, by Region: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 5.1 North America Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 5.2 North America Treatment for Neglected Tropical Disease Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %)
Table 5.3 U.S. Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 5.4 Canada Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.1 Europe Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 6.2 Europe Treatment for Neglected Tropical Disease Market Forecast, By Country: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 6.3 Germany Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.4 France Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.5 U.K. Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.6 Italy Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.7 Spain Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.8 Rest of Europe Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 7.1 Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report